FIELD: genetic engineering and biotechnology.
SUBSTANCE: invention relates to a de novo genetic construct that provides heterologous expression of the S-protein receptor-binding domain in a fused polypeptide chain with a nucleocapsid protein.
EFFECT: invention can be used in the heterologous synthesis of the said chimeric protein in recombinant producer strains, as well as in obtaining its homogeneous preparation suitable for structural and biophysical studies.
1 cl, 4 dwg
             
         
            
              
                | Title | Year | Author | Number | 
							
              
                | ARTIFICIAL GENE CODING A BICISTRONIC STRUCTURE FORMED BY RECEPTOR-BINDING DOMAIN SEQUENCES OF THE GLYCOPROTEIN S OF THE SARS-COV-2 CORONAVIRUS, P2A-PEPTIDE AND GLYCOPROTEIN G VSV, RECOMBINANT PLASMID PSTEM-RVSV-STBL_RBD_SC2, PROVIDING EXPRESSION OF ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-STBL_RBD_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS | 2020 | 
										Imatdinov Ilnaz RamisovichBochkareva Mariya DmitrievnaPrudnikova Elena YurevnaTishin Anton EvgenevichPyankov Oleg ViktorovichGavrilova Elena VasilevnaMaksyutov Rinat Amirovich | RU2733831C1 | 
							
              
                | ARTIFICIAL GENE STBL_RBD_TRM_SC2, CODING A BICISTRONIC STRUCTURE FORMED BY THE SARS-COV-2 CORONAVIRUS GLYCOPROTEIN S RECEPTOR-BINDING DOMAIN SEQUENCES, TRANSMEMBRANE REGION, P2A-PEPTIDE AND GLYCOPROTEIN G VSV, RECOMBINANT PLASMID PSTEM-RVSV-STBL_RBD_TRM_SC2, PROVIDING EXPRESSION OF ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-STBL_RBD_TRM_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS | 2020 | 
										Imatdinov Ilnaz RamisovichBochkareva Mariya DmitrievnaPrudnikova Elena YurevnaTishin Anton EvgenevichPyankov Oleg ViktorovichGavrilova Elena VasilevnaMaksyutov Rinat Amirovich | RU2733832C1 | 
							
              
                | INTEGRATIVE PLASMID VECTOR PVEAL2-S-RBD, PROVIDING THE EXPRESSION AND SECRETION OF THE RECOMBINANT RECEPTOR-BINDING DOMAIN (RBD) OF THE SARS-COV-2 CORONAVIRUS IN MAMMALIAN CELLS, THE RECOMBINANT CHO-K1-RBD CELL LINE STRAIN AND THE RECOMBINANT SARS-COV-2 RBD PROTEIN PRODUCED BY THE SPECIFIED STRAIN OF THE CELL LINE CHO-K1-RBD | 2021 | 
										Merkuleva Yuliya AleksandrovnaShcherbakov Dmitrij NikolaevichBelenkaya Svetlana ValerevnaIsaeva Anastasiya AleksandrovnaNesmeyanova Valentina SergeevnaShanshin Daniil VasilevichVolkova Natalya VyacheslavovnaIlichev Aleksandr AlekseevichKarpenko Larisa Ivanovna | RU2752858C1 | 
							
              
                | INTEGRATIVE PLASMID VECTOR pVEAL3-RBDdel, PROVIDING SYNTHESIS AND SECRETION OF RECOMBINANT PROTEIN OF RECEPTOR-BINDING DOMAIN RBDdelta OF CORONAVIRUS SARS-CoV-2 IN MAMMALIAN CELLS, RECOMBINANT CELL LINE STRAIN CHO-K1-RBDdelta AND RECOMBINANT PROTEIN RBDdelta SARS-CoV-2 PRODUCED BY CELL LINE STRAIN | 2023 | 
										Nesmeyanova Valentina SergeevnaMerkuleva Yuliya AleksandrovnaIsaeva Anastasiya AleksandrovnaShcherbakov Dmitrij NikolaevichVolkova Natalya VyacheslavovnaBelenkaya Svetlana ValerevnaBorgoyarkova Mariya BorisovnaVolosnikova Ekaterina AleksandrovnaEsina Tatyana IgorevnaZajkovskaya Anna VladimirovnaPyankov Oleg ViktorovichIlichev Aleksandr Alekseevich | RU2816175C1 | 
							
              
                | ARTIFICIAL ECTOS_SC2 GENE ENCODING AN ECTODOMAIN OF THE SARS-COV-2 CORONAVIRUS S GLYCOPROTEIN WITH A C-TERMINAL TRIMERIZATION DOMAIN, A RECOMBINANT PLASMID PSTEM-RVSV-ECTOS_SC2, WHICH PROVIDES EXPRESSION OF THE ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-ECTOS_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS | 2020 | 
										Imatdinov Ilnaz RamisovichBochkareva Mariya DmitrievnaPrudnikova Elena YurevnaTishin Anton EvgenevichPyankov Oleg ViktorovichGavrilova Elena VasilevnaMaksyutov Rinat Amirovich | RU2733834C1 | 
							
              
                | RECOMBINANT PLASMID pVEAL3-XBB.1.5, WHICH PROVIDES SYNTHESIS AND SECRETION OF RECEPTOR-BINDING DOMAIN RBD S OF SARS-CoV-2 PROTEIN OF VARIANT XBB.1.5, AND RECOMBINANT STRAIN CHO-XBB.1.5 - PRODUCER OF RECEPTOR-BINDING DOMAIN RBD S PROTEIN SARS-CoV-2 VERSION XBB.1.5 INTENDED FOR PRODUCING IMMUNOBIOLOGICAL PREPARATIONS | 2024 | 
										Isaeva Anastasiya AleksandrovnaVolkova Natalya VyacheslavovnaShcherbakov Dmitrij NikolaevichNesmeyanova Valentina Sergeevna | RU2839373C1 | 
							
              
                | MONOCLONAL ANTIBODY TO RDB FRAGMENT IN COMPOSITION OF SARS-COV-2 S PROTEIN | 2020 | 
										Shakhparonov Mikhail IvanovichPavliukov Marat SamvelovichAntipova Nadezhda Viktorovna | RU2744274C1 | 
							
              
                | RECOMBINANT RBD S-PROTEIN OF CORONAVIRUS SARS-CoV-2 AND METHOD FOR ITS PRODUCTION | 2023 | 
										Tsyganova Mariya IgorevnaNovikov Viktor VladimirovichNovikov Dmitrij ViktorovichMelentev Dmitrij AleksandrovichMokhonov Vladislav ValerevichLapin Vladislav AleksandrovichMokhonova Ekaterina Valerevna | RU2833839C1 | 
							
              
                | ARTIFICIAL GENE N1NEW, ENCODING NUCLEOCAPSID PROTEIN OF CORONAVIRUS SARS-CoV-2, AND RECOMBINANT PLASMID PET-28A-N1NEW, PROVIDING EXPRESSION OF THE ARTIFICIAL GENE | 2021 | 
										Belozerova Natalya SergeevnaPletyukhina Yuliya VladimirovnaRabdano Sevastyan OlegovichSavelev Nikita SergeevichFakhretdinova Liliya NiyazovnaTrukhin Viktor PavlovichEvtushenko Anatolij EduardovichMusa Rakhimovich KhaitovSkvortsova Veronika Igorevna | RU2762962C1 | 
							
              
                | POLYPEPTIDE MODULE FOR BINDING CONSERVATIVE EPITOPE OF RECEPTOR-BINDING DOMAIN OF SPIKE PROTEIN OF SARS-CoV-2 CORONAVIRUS | 2022 | 
										Tillib Sergej VladimirovichVorobev Pavel Olegovich | RU2809183C1 |